Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.. Additionally we are shipping Natural Cytotoxicity Triggering Receptor 2 Proteins (6) and Natural Cytotoxicity Triggering Receptor 2 Kits (3) and many more products for this protein.
Showing 10 out of 104 products:
Human Monoclonal NCR2 Primary Antibody for FACS - ABIN2661055
Cantoni, Bottino, Vitale, Pessino, Augugliaro, Malaspina, Parolini, Moretta, Moretta, Biassoni: NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. in The Journal of experimental medicine 1999
Show all 7 references for ABIN2661055
Human Monoclonal NCR2 Primary Antibody for FACS, ICFC - ABIN2658621
Allcock, Barrow, Forbes, Beck, Trowsdale: The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44. in European journal of immunology 2003
Show all 7 references for ABIN2658621
Human Monoclonal NCR2 Primary Antibody for BR, FACS - ABIN2657757
Cantoni, Ponassi, Biassoni, Conte, Spallarossa, Moretta, Moretta, Bolognesi, Bordo: The three-dimensional structure of the human NK cell receptor NKp44, a triggering partner in natural cytotoxicity. in Structure (London, England : 1993) 2003
Show all 6 references for ABIN2657757
Human Monoclonal NCR2 Primary Antibody for FACS, ICFC - ABIN2663382
Sommaggio, Cohnen, Watzl, Costa: Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes. in Journal of immunology (Baltimore, Md. : 1950) 2012
Show all 6 references for ABIN2663382
Human Monoclonal NCR2 Primary Antibody for FACS - ABIN4896418
Longman, Diehl, Victorio, Huh, Galan, Miraldi, Swaminath, Bonneau, Scherl, Littman: CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. in The Journal of experimental medicine 2014
Human Monoclonal NCR2 Primary Antibody for ELISA, WB - ABIN165438
Biassoni, Cantoni, Marras, Giron-Michel, Falco, Moretta, Dimasi: Human natural killer cell receptors: insights into their molecular function and structure. in Journal of cellular and molecular medicine 2004
On CD56 (show NCAM1 Antibodies)(+) CD3 (show CD3 Antibodies)(-) cells, NKp44 and NKp46 (show NCR1 Antibodies) expressions were high in the acute hepatitis E patients, whereas NKp30 (show NCR3 Antibodies), NKp44, NKp46 (show NCR1 Antibodies) and NKG2D (show KLRK1 Antibodies) were high in the recovered individuals.
demonstrated that the mitogen and iK562 exposure to peripheral blood mononuclear cells can significantly improve NK activity which is co-related to the higher expression of NKp44 and NKG2D (show KLRK1 Antibodies)
NCR(+) ILC3 from skin and blood of psoriasis patients produced IL-22 (show IL22 Antibodies), which is regarded as a key driver of epidermal thickening, suggesting that NCR(+) ILC3 may participate in psoriasis pathology.
Balance between activating NKG2D (show KLRK1 Antibodies), DNAM-1 (show CD226 Antibodies), NKp44 and NKp46 (show NCR1 Antibodies) and inhibitory CD94 (show KLRD1 Antibodies)/NKG2A (show KLRC1 Antibodies) receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
NKp44+ ILC3 are expressed in human skin and blood and may have a role in psoriasis pathogenesis
Expression of NKp44 ligand by normal articular chondrocytes is not involved in their killing by unstimulated NK cells; however, it is responsible for anti-chondrocyte cytotoxicity mediated by long-term activated NK cells.
MLL5 (show MLL5 Antibodies) is a cellular ligand for the natural cytotoxicity receptor NKp44.
Natural killer cells in HIV controller patients express an activated effector phenotype and do not up-regulate NKp44 on IL-2 (show IL2 Antibodies) stimulation.
Novel interaction between proliferating cell nuclear antigen (show PCNA Antibodies) and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.
While interaction of TLR2 (show TLR2 Antibodies) with mycobacterial cell wall promotes activation of resting NK cells and IFN-gamma (show IFNG Antibodies) production, NKp44 interaction with its putative ligands could play a secondary role in maintaining cell activation
Cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis.
natural cytotoxicity triggering receptor 2
, NK cell activating receptor (NKp44)
, NK cell-activating receptor
, lymphocyte antigen 95 (activating NK-receptor; NK-p44)
, lymphocyte antigen 95 homolog (activating NK-receptor; NK-p44)
, natural killer cell p44-related protein